Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Phosphorothioate oligonucleotide targeted to apolipoprotein C-III

EU orphan designation number: EU/3/14/1249   
Active ingredient: Phosphorothioate oligonucleotide targeted to apolipoprotein C-III
Indication: Treatment of familial chylomicronemia syndrome
Sponsor: Akcea Therapeutics UK Ltd.
Office 32, 19-21 Crawford Street, London W1H 1PJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/03/2014 Orphan designation EMA/OD/180/13 (2014)1224 of 19/02/2014
07/04/2016 Change of name and/or address of sponsor
10/07/2017 Transfer of orphan designation EMA/OD/180/13/T/01 (2017)4921 of 06/07/2017